PATRICIA WEAVER: Open Payments
NPI 1356456628 · BENNETTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 76 payments from 18 companies in 2025. Trend: 2023 $713 · 2024 $937 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $348 |
| Novo Nordisk Inc | 11 | $316 |
| Merck Sharp & Dohme LLC | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Corcept Therapeutics | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Insulet Corporation | 3 | $61 |
| Lilly USA, LLC | 3 | $42 |
| Lundbeck LLC | 2 | $40 |
Products named: VRAYLAR, Ozempic, VERQUVO, CAPLYTA, Korlym, Kerendia, Wegovy, FARXIGA.
Industry payments across SC — which companies pay providers there.
